Zacks Investment Research upgraded TherapeuticsMD Inc (NASDAQ:TXMD) to Hold in a report released today.
- Updated: September 24, 2016
Zacks Investment Research has upgraded TherapeuticsMD Inc (NASDAQ:TXMD) to Hold in a report released on Thursday September 22, 2016.
Just yesterday TherapeuticsMD Inc (NASDAQ:TXMD) traded 2.40% higher at $6.32. TherapeuticsMD Inc’s 50-day moving average is $6.94 and its 200-day moving average is $7.64. The last stock price is down -16.06% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 1,912,065 shares of TXMD traded hands, up from an average trading volume of 1,298,720
Recent Performance Chart
TherapeuticsMD Inc has 52 week low of $5.18 and a 52 week high of $11.26 and has a market capitalization of $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 5 brokerages have issued a ratings update on the company. The average stock price target is $19.30 with 3 brokerages rating the stock a strong buy, 2 brokerages rating the stock a buy, 0 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
Brief Synopsis On TherapeuticsMD Inc (NASDAQ:TXMD)
TherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. The Company's product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.